Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
SciScore for 10.1101/2020.08.06.20162446: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: As such, it was not under the oversight of the institutional review board.
IACUC: This manuscript was evaluated and approved by the institutional publication review committee.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources 15 Antibody detection was performed from serum or plasma samples, collected in appropriate separator tubes, using DiaSorin Liaison XL SARS-CoV-2 IgG S1/S2 assay (DiaSorin, Saluggia, Italy). DiaSorin , Saluggia , Italy) .suggested: NoneSeropositivity was defined at presence of anti-SARS-CoV-2 IgG antibodies ≥ 15 absorbance units … SciScore for 10.1101/2020.08.06.20162446: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: As such, it was not under the oversight of the institutional review board.
IACUC: This manuscript was evaluated and approved by the institutional publication review committee.Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Antibodies Sentences Resources 15 Antibody detection was performed from serum or plasma samples, collected in appropriate separator tubes, using DiaSorin Liaison XL SARS-CoV-2 IgG S1/S2 assay (DiaSorin, Saluggia, Italy). DiaSorin , Saluggia , Italy) .suggested: NoneSeropositivity was defined at presence of anti-SARS-CoV-2 IgG antibodies ≥ 15 absorbance units per milliliters (AU/mL), as recommended by the manufacturer. anti-SARS-CoV-2 IgGsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-
